Regulation of phase II biotransformation enzymes by steroid hormones

Current Drug Metabolism

Volumn 12, Issue 2, 2011, Pages 104-123

  Kohalmy, Krisztina ^a   Vrzal, Radim ^b  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^b PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Androgens; Cancer; Estrogens; Genetic polymorphism; Glucocorticoids; GLYAT; Nuclear receptors

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; BICALUTAMIDE; CATECHOL METHYLTRANSFERASE; DEXAMETHASONE; DRUG METABOLIZING ENZYME; FLUTAMIDE; GLUCOCORTICOID; GLUCURONOSYLTRANSFERASE; GLUTATHIONE TRANSFERASE; METRIBOLONE; MIFEPRISTONE; PROGESTERONE; SEX HORMONE; STEROID HORMONE; SULFOTRANSFERASE; THIOPURINE METHYLTRANSFERASE; VITAMIN D; XENOBIOTIC AGENT;

ARTICLE; CONJUGATION; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; DRUG METABOLISM; DRUG TRANSPORT; ENZYME ACTIVITY; ENZYME REGULATION; GENE CONTROL; GENE EXPRESSION; GENE FREQUENCY; GENETIC TRANSCRIPTION; GLUCURONIDATION; HUMAN; NONHUMAN; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION;

ANIMALS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOCORTICOIDS; GONADAL STEROID HORMONES; HUMANS; METABOLIC DETOXICATION, PHASE II; MODELS, BIOLOGICAL; XENOBIOTICS;

EID: 79952796042     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920011795016872     Document Type: Article

References (249)

1. Ritter, J. K. Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions. Chem. Biol. Interact., 2000, 129(1-2), 171-193. (Pubitemid 32061059)
2. Glatt, H. Sulfotransferases in the bioactivation of xenobiotics. Chem Biol Interact, 2000, 129(1-2), 141-170. (Pubitemid 32061058)
3. Jancova, P.; Anzenbacher, P.; Anzenbacherova, E. Phase II drug metabolizing enzymes. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 154(2), 103-116.
4. Oakley, A. J. Glutathione transferases: New functions. Curr. Opin. Struct. Biol., 2005, 15(6), 716-723. (Pubitemid 41668529)
5. Bock, K. W. Functions and transcriptional regulation of adult human hepatic UDP-glucuronosyl-transferases (UGTs): Mechanisms responsible for interindividual variation of UGT levels. Biochem Pharmacol, 80(6), 771-777.
6. Hayes, J. D.; Flanagan, J. U.; Jowsey, I. R. Glutathione transferases. Annu. Rev. Pharmacol. Toxicol, 2005, 45, 51-88. (Pubitemid 40261798)
7. Ishii, Y.; Nurrochmad, A.; Yamada, H. Modulation of UDPglucuronosyltransferase activity by endogenous compounds. Drug Metab. Pharmacokinet., 25(2), 134-148.
8. Verreault, M.; Kaeding, J.; Caron, P.; Trottier, J.; Grosse, L.; Houssin, E.; Paquet, S.; Perreault, M.; Barbier, O. Regulation of endobiotics glucuronidation by ligand-activated transcription factors: Physiological function and therapeutic potential. Drug Metab. Rev, 42(1), 106-118.
9. Mackenzie, P. I.; Bock, K. W.; Burchell, B.; Guillemette, C.; Ikushiro, S.; Iyanagi, T.; Miners, J. O.; Owens, I. S.; Nebert, D. W. Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet. Genomics, 2005, 15(10), 677-685. (Pubitemid 41345319)
10. Mackenzie, P. I.; Gregory, P. A.; Gardner-Stephen, D. A.; Lewinsky, R. H.; Jorgensen, B. R.; Nishiyama, T.; Xie, W.; Radominska-Pandya, A. Regulation of UDP glucuronosyltransferase genes. Curr. Drug Metab., 2003, 4(3), 249-257. (Pubitemid 36656482)
11. Guillemette, C. Pharmacogenomics of human UDP-glucuronosyltransferase enzymes. Pharmacogenomics J., 2003, 3(3), 136-158. (Pubitemid 36850156)
12. Monaghan, G.; Clarke, D. J.; Povey, S.; See, C. G.; Boxer, M.; Burchell, B. Isolation of a human YAC contig encompassing a cluster of UGT2 genes and its regional localization to chromosome 4q13. Genomics, 1994, 23(2), 496-499. (Pubitemid 24308276)
13. Girard, C.; Barbier, O.; Veilleux, G.; El-Alfy, M.; Belanger, A. Human uridine diphosphate-glucuronosyltransferase UGT2B7 conjugates mineralocorticoid and glucocorticoid metabolites. Endocrinology, 2003, 144(6), 2659-2668. (Pubitemid 36629919)
14. Soars, M. G.; Petullo, D. M.; Eckstein, J. A.; Kasper, S. C.; Wrighton, S. A. An assessment of udp-glucuronosyltransferase induction using primary human hepatocytes. Drug Metab. Dispos., 2004, 32(1), 140-148. (Pubitemid 38112546)
15. Izukawa, T.; Nakajima, M.; Fujiwara, R.; Yamanaka, H.; Fukami, T.; Takamiya, M.; Aoki, Y.; Ikushiro, S.; Sakaki, T.; Yokoi, T. Quantitative analysis of UDP-glucuronosyltransferase (UGT) 1A and UGT2B expression levels in human livers. Drug Metab. Dispos., 2009, 37(8), 1759-1768.
16. Shelby, M. K.; Cherrington, N. J.; Vansell, N. R.; Klaassen, C. D. Tissue mRNA expression of the rat UDP-glucuronosyltransferase gene family. Drug Metab. Dispos., 2003, 31(3), 326-333. (Pubitemid 36249688)
17. Strassburg, C. P.; Oldhafer, K.; Manns, M. P.; Tukey, R. H. Differential expression of the UGT1A locus in human liver, biliary, and gastric tissue: Identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue. Mol. Pharmacol., 1997, 52(2), 212-220. (Pubitemid 27349612)
18. Bosma, P. J.; Seppen, J.; Goldhoorn, B.; Bakker, C.; Oude Elferink, R. P.; Chowdhury, J. R.; Chowdhury, N. R.; Jansen, P. L. Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. J. Biol. Chem., 1994, 269(27), 17960-17964. (Pubitemid 24206189)
19. Bosma, P. J.; Chowdhury, J. R.; Bakker, C.; Gantla, S.; de Boer, A.; Oostra, B. A.; Lindhout, D.; Tytgat, G. N.; Jansen, P. L.; Oude Elferink, R. P.; et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N. Engl. J. Med., 1995, 333(18), 1171-1175.
20. Ebner, T.; Remmel, R. P.; Burchell, B. Human bilirubin UDPglucuronosyltransferase catalyzes the glucuronidation of ethinylestradiol. Mol. Pharmacol., 1993, 43(4), 649-654. (Pubitemid 23112743)
21. Buetler, T. M.; Gallagher, E. P.; Wang, C.; Stahl, D. L.; Hayes, J. D.; Eaton, D. L. Induction of phase I and phase II drugmetabolizing enzyme mRNA, protein, and activity by BHA, ethoxyquin, and oltipraz. Toxicol. Appl. Pharmacol., 1995, 135(1), 45-57.
22. Ritter, J. K.; Kessler, F. K.; Thompson, M. T.; Grove, A. D.; Auyeung, D. J.; Fisher, R. A. Expression and inducibility of the human bilirubin UDP-glucuronosyltransferase UGT1A1 in liver and cultured primary hepatocytes: Evidence for both genetic and environmental influences. Hepatology, 1999, 30(2), 476-484. (Pubitemid 29357514)
23. Prochaska, H. J.; Talalay, P. Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine liver. Cancer Res, 1988, 48(17), 4776-4782.
24. Xie, W.; Yeuh, M. F.; Radominska-Pandya, A.; Saini, S. P.; Negishi, Y.; Bottroff, B. S.; Cabrera, G. Y.; Tukey, R. H.; Evans, R. M. Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor. Proc. Natl. Acad. Sci. U S A, 2003, 100(7), 4150-4155. (Pubitemid 36418172)
25. Sugatani, J.; Kojima, H.; Ueda, A.; Kakizaki, S.; Yoshinari, K.; Gong, Q. H.; Owens, I. S.; Negishi, M.; Sueyoshi, T. The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR. Hepatology, 2001, 33(5), 1232-1238. (Pubitemid 32378224)
26. Park, J.; Chen, L.; Shade, K.; Lazarus, P.; Seigne, J.; Patterson, S.; Helal, M.; Pow-Sang, J. Asp85tyr polymorphism in the udpglucuronosyltransferase (UGT) 2B15 gene and the risk of prostate cancer. J. Urol., 2004, 171(6 Pt 1), 2484-2488. (Pubitemid 38625520)
27. Park, J.; Chen, L.; Ratnashinge, L.; Sellers, T. A.; Tanner, J. P.; Lee, J. H.; Dossett, N.; Lang, N.; Kadlubar, F. F.; Ambrosone, C. B.; Zachariah, B.; Heysek, R. V.; Patterson, S.; Pow-Sang, J. Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men. Cancer Epidemiol. Biomarkers Prev., 2006, 15(8), 1473-1478. (Pubitemid 44299318)
28. Sutherland, L.; Ebner, T.; Burchell, B. The expression of UDPglucuronosyltransferases of the UGT1 family in human liver and kidney and in response to drugs. Biochem. Pharmacol., 1993, 45(2), 295-301. (Pubitemid 23042627)
29. Ferrari, L.; Herber, R.; Batt, A. M.; Siest, G. Differential effects of human recombinant interleukin-1 beta and dexamethasone on hepatic drug-metabolizing enzymes in male and female rats. Biochem. Pharmacol., 1993, 45(11), 2269-2277. (Pubitemid 23171088)
30. Strasser, S. I.; Mashford, M. L.; Desmond, P. V. Regulation of uridine diphosphate glucuronosyltransferase during the acute-phase response. J. Gastroenterol. Hepatol., 1998, 13(1), 88-94. (Pubitemid 28137765)
31. Li, Y. Q.; Prentice, D. A.; Howard, M. L.; Mashford, M. L.; Desmond, P. V. The effect of hormones on the expression of five isoforms of UDP-glucuronosyltransferase in primary cultures of rat hepatocytes. Pharm. Res., 1999, 16(2), 191-197. (Pubitemid 29135121)
32. Jemnitz, K.; Veres, Z.; Monostory, K.; Vereczkey, L. Glucuronidation of thyroxine in primary monolayer cultures of rat hepatocytes: In vitro induction of UDP-glucuronosyltranferases by methylcholanthrene, clofibrate, and dexamethasone alone and in combination. Drug Metab. Dispos., 2000, 28(1), 34-37. (Pubitemid 30027509)
33. Sugatani, J.; Nishitani, S.; Yamakawa, K.; Yoshinari, K.; Sueyoshi, T.; Negishi, M.; Miwa, M. Transcriptional regulation of human UGT1A1 gene expression: Activated glucocorticoid receptor enhances constitutive androstane receptor/pregnane X receptormediated UDP-glucuronosyltransferase 1A1 regulation with glucocorticoid receptor-interacting protein 1. Mol. Pharmacol., 2005, 67(3), 845-855. (Pubitemid 40365332)
34. Usui, T.; Kuno, T.; Mizutani, T. Induction of human UDPglucuronosyltransferase 1A1 by cortisol-GR. Mol. Biol. Rep., 2006, 33(2), 91-96. (Pubitemid 43992643)
35. Kanou, M.; Usui, T.; Ueyama, H.; Sato, H.; Ohkubo, I.; Mizutani, T. Stimulation of transcriptional expression of human UDPglucuronosyltransferase 1A1 by dexamethasone. Mol. Biol.Rep., 2004, 31(3), 151-158. (Pubitemid 40941142)
36. Usui, T.; Kuno, T.; Ueyama, H.; Ohkubo, I.; Mizutani, T. Proximal HNF1 element is essential for the induction of human UDPglucuronosyltransferase 1A1 by glucocorticoid receptor. Biochem. Pharmacol., 2006, 71(5), 693-701. (Pubitemid 43122002)
37. Onica, T.; Nichols, K.; Larin, M.; Ng, L.; Maslen, A.; Dvorak, Z.; Pascussi, J. M.; Vilarem, M. J.; Maurel, P.; Kirby, G. M. Dexamethasone-mediated up-regulation of human CYP2A6 involves the glucocorticoid receptor and increased binding of hepatic nuclear factor 4 alpha to the proximal promoter. Mol. Pharmacol., 2008, 73(2), 451-460. (Pubitemid 351159215)
38. Thum, T.; Erpenbeck, V. J.; Moeller, J.; Hohlfeld, J. M.; Krug, N.; Borlak, J. Expression of xenobiotic metabolizing enzymes in different lung compartments of smokers and nonsmokers. Environ. Health Perspect., 2006, 114(11), 1655-1661. (Pubitemid 44718269)
39. Kitamura, M.; Kasai, A. Cigarette smoke as a trigger for the dioxin receptor-mediated signaling pathway. Cancer Lett, 2007, 252(2), 184-194. (Pubitemid 46809788)
40. Kaeding, J.; Belanger, J.; Caron, P.; Verreault, M.; Belanger, A.; Barbier, O. Calcitrol (1alpha,25-dihydroxyvitamin D3) inhibits androgen glucuronidation in prostate cancer cells. Mol. Cancer Ther., 2008, 7(2), 380-390. (Pubitemid 351302531)
41. Trump, D. L.; Deeb, K. K.; Johnson, C. S. Vitamin D: Considerations in the continued development as an agent for cancer prevention and therapy. Cancer J, 16(1), 1-9.
42. Srinivas, S.; Feldman, D. A phase II trial of calcitriol and naproxen in recurrent prostate cancer. Anticancer. Res., 2009, 29(9), 3605-3610.
43. Becedas, L.; Lundgren, B.; De Pierre, J. W. Characterization of the UDP-glucuronosyltransferase isoenzyme expressed in rat ovary and its regulation by gonadotropins. Biochem. J., 1998, 332 (Pt 1), 51-55. (Pubitemid 28239317)
44. Jeong, H.; Choi, S.; Song, J. W.; Chen, H.; Fischer, J. H. Regulation of UDP-glucuronosyltransferase (UGT) 1A1 by progesterone and its impact on labetalol elimination. Xenobiotica, 2008, 38(1), 62-75.
45. Chouinard, S.; Yueh, M. F.; Tukey, R. H.; Giton, F.; Fiet, J.; Pelletier, G.; Barbier, O.; Belanger, A. Inactivation by UDPglucuronosyltransferase enzymes: The end of androgen signaling. J. Steroid Biochem. Mol. Biol., 2008, 109(3-5), 247-253.
46. Barbier, O.; Lapointe, H.; El Alfy, M.; Hum, D. W.; Belanger, A. Cellular localization of uridine diphosphoglucuronosyltransferase 2B enzymes in the human prostate by in situ hybridization and immunohistochemistry. J. Clin. Endocrinol. Metab., 2000, 85(12), 4819-4826. (Pubitemid 32157673)
47. Barbier, O.; Belanger, A. Inactivation of androgens by UDPglucuronosyltransferases in the human prostate. Best. Pract. Res. Clin. Endocrinol. Metab., 2008, 22(2), 259-270. (Pubitemid 351611947)
48. Guillemette, C.; Hum, D. W.; Belanger, A. Regulation of steroid glucuronosyltransferase activities and transcripts by androgen in the human prostatic cancer LNCaP cell line. Endocrinology, 1996, 137(7), 2872-2879. (Pubitemid 26192181)
49. Bao, B. Y.; Chuang, B. F.; Wang, Q.; Sartor, O.; Balk, S. P.; Brown, M.; Kantoff, P. W.; Lee, G. S. Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes. Prostate, 2008, 68(8), 839-848. (Pubitemid 351845215)
50. Chouinard, S.; Barbier, O.; Belanger, A. UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells. J. Biol. Chem., 2007, 282(46), 33466-33474. (Pubitemid 350159554)
51. Kanaya, J.; Takashima, M.; Koh, E.; Namiki, M. Androgenindependent growth in LNCaP cell lines and steroid uridine diphosphate-glucuronosyltransferase expression. Asian J. Androl., 2003, 5(1), 9-13. (Pubitemid 36417093)
52. Strasser, S. I.; Smid, S. A.; Mashford, M. L.; Desmond, P. V. Sex hormones differentially regulate isoforms of UDPglucuronosyltransferase. Pharm. Res., 1997, 14(9), 1115-1121. (Pubitemid 27432530)
53. Magnanti, M.; Giuliani, L.; Gandini, O.; Gazzaniga, P.; Santiemma, V.; Ciotti, M.; Saccani, G.; Frati, L.; Agliano, A. M. Follicle-stimulating hormone, testosterone, and hypoxia differentially regulate UDP-glucuronosyltransferase 1 isoforms expression in rat sertoli and peritubular myoid cells. J. Steroid Biochem. Mol. Biol., 2000, 74(3), 149-155.
54. Stern, S. T.; Tallman, M. N.; Miles, K. K.; Ritter, J. K.; Smith, P. C. Androgen regulation of renal uridine diphosphoglucuronosyltransferase 1A1 in rats. Drug Metab. Dispos., 2008, 36(9), 1737-1739.
55. Harrington, W. R.; Sengupta, S.; Katzenellenbogen, B. S. Estrogen regulation of the glucuronidation enzyme UGT2B15 in estrogen receptor-positive breast cancer cells. Endocrinology, 2006, 147(8), 3843-3850. (Pubitemid 44079389)
56. Hu, D. G.; Mackenzie, P. I. Estrogen receptor alpha, fos-related antigen-2, and c-Jun coordinately regulate human UDP glucuronosyltransferase 2B15 and 2B17 expression in response to 17beta-estradiol in MCF-7 cells. Mol. Pharmacol., 2009, 76(2), 425-439.
57. Fitzpatrick, S. L.; Berrodin, T. J.; Jenkins, S. F.; Sindoni, D. M.; Deecher, D. C.; Frail, D. E. Effect of estrogen agonists and antagonists on induction of progesterone receptor in a rat hypothalamic cell line. Endocrinology, 1999, 140(9), 3928-3937. (Pubitemid 30647086)
58. Markiewicz, L.; Garey, J.; Adlercreutz, H.; Gurpide, E. In vitro bioassays of non-steroidal phytoestrogens. J. Steroid Biochem. Mol. Biol., 1993, 45(5), 399-405. (Pubitemid 23163017)
59. Pfeiffer, E.; Treiling, C. R.; Hoehle, S. I.; Metzler, M. Isoflavones modulate the glucuronidation of estradiol in human liver microsomes. Carcinogenesis, 2005, 26(12), 2172-2178. (Pubitemid 41672205)
60. Hanet, N.; Lancon, A.; Delmas, D.; Jannin, B.; Chagnon, M. C.; Cherkaoui-Malki, M.; Latruffe, N.; Artur, Y.; Heydel, J. M. Effects of endocrine disruptors on genes associated with 17beta-estradiol metabolism and excretion. Steroids, 2008, 73(12), 1242-1251.
61. Chen, H.; Yang, K.; Choi, S.; Fischer, J. H.; Jeong, H. Upregulation of UDP-glucuronosyltransferase (UGT) 1A4 by 17betaestradiol: A potential mechanism of increased lamotrigine elimination in pregnancy. Drug Metab. Dispos., 2009, 37(9), 1841-1847.
62. Ishii, Y.; Takami, A.; Tsuruda, K.; Kurogi, A.; Yamada, H.; Oguri, K. Induction of two UDP-glucuronosyltransferase isoforms sensitive to phenobarbital that are involved in morphine glucuronidation: Production of isoform-selective antipeptide antibodies toward UGT1.1r and UGT2B1. Drug Metab. Dispos., 1997, 25(2), 163-167. (Pubitemid 27086116)
63. Nuwaysir, E. F.; Daggett, D. A.; Jordan, V. C.; Pitot, H. C. Phase II enzyme expression in rat liver in response to the antiestrogen tamoxifen. Cancer Res., 1996, 56(16), 3704-3710. (Pubitemid 26272016)
64. Glatt, H. Sulfation and sulfotransferases 4: Bioactivation of mutagens via sulfation. Faseb J., 1997, 11(5), 314-321. (Pubitemid 27193935)
65. Glatt, H.; Davis, W.; Meinl, W.; Hermersdorfer, H.; Venitt, S.; Phillips, D. H. Rat, but not human, sulfotransferase activates a tamoxifen metabolite to produce DNA adducts and gene mutations in bacteria and mammalian cells in culture. Carcinogenesis, 1998, 19(10), 1709-1713. (Pubitemid 28474633)
66. Li, X.; Clemens, D. L.; Cole, J. R.; Anderson, R. J. Characterization of human liver thermostable phenol sulfotransferase (SULT1A1) allozymes with 3,3',5-triiodothyronine as the substrate. J. Endocrinol., 2001, 171(3), 525-532. (Pubitemid 34026367)
67. Comer, K. A.; Falany, C. N. Immunological characterization of dehydroepiandrosterone sulfotransferase from human liver and adrenal. Mol. Pharmacol., 1992, 41(4), 645-651. (Pubitemid 23021450)
68. Cook, I. T.; Duniec-Dmuchowski, Z.; Kocarek, T. A.; Runge- Morris, M.; Falany, C. N. 24-hydroxycholesterol sulfation by human cytosolic sulfotransferases: Formation of monosulfates and disulfates, molecular modeling, sulfatase sensitivity, and inhibition of liver x receptor activation. Drug Metab. Dispos., 2009, 37(10), 2069-2078.
69. Coughtrie, M. W.; Sharp, S.; Maxwell, K.; Innes, N. P. Biology and function of the reversible sulfation pathway catalysed by human sulfotransferases and sulfatases. Chem. Biol. Interact., 1998, 109(1-3), 3-27. (Pubitemid 28161098)
70. Blanchard, R. L.; Freimuth, R. R.; Buck, J.; Weinshilboum, R. M.; Coughtrie, M. W. A proposed nomenclature system for the cytosolic sulfotransferase (SULT) superfamily. Pharmacogenetics, 2004, 14(3), 199-211. (Pubitemid 38373115)
71. Her, C.; Wood, T. C.; Eichler, E. E.; Mohrenweiser, H. W.; Ramagli, L. S.; Siciliano, M. J.; Weinshilboum, R. M. Human hydroxysteroid sulfotransferase SULT2B1: Two enzymes encoded by a single chromosome 19 gene. Genomics, 1998, 53(3), 284-295. (Pubitemid 28527630)
72. Liyou, N. E.; Buller, K. M.; Tresillian, M. J.; Elvin, C. M.; Scott, H. L.; Dodd, P. R.; Tannenberg, A. E.; McManus, M. E. Localization of a brain sulfotransferase, SULT4A1, in the human and rat brain: An immunohistochemical study. J. Histochem. Cytochem., 2003, 51(12), 1655-1664. (Pubitemid 37475438)
73. Takahashi, S.; Sakakibara, Y.; Mishiro, E.; Kouriki, H.; Nobe, R.; Kurogi, K.; Yasuda, S.; Liu, M. C.; Suiko, M. Molecular cloning, expression and characterization of a novel mouse SULT6 cytosolic sulfotransferase. J. Biochem., 2009, 146(3), 399-405.
74. Falany, C. N.; Comer, K. A.; Dooley, T. P.; Glatt, H. Human dehydroepiandrosterone sulfotransferase. Purification, molecular cloning, and characterization. Ann. N. Y. Acad. Sci., 1995, 774, 59-72. (Pubitemid 26140360)
75. Falany, C. N.; Vazquez, M. E.; Heroux, J. A.; Roth, J. A. Purification and characterization of human liver phenol-sulfating phenol sulfotransferase. Arch. Biochem. Biophys., 1990, 278(2), 312-318. (Pubitemid 20126057)
76. Dooley, T. P.; Haldeman-Cahill, R.; Joiner, J.; Wilborn, T. W. Expression profiling of human sulfotransferase and sulfatase gene superfamilies in epithelial tissues and cultured cells. Biochem. Biophys. Res. Commun., 2000, 277(1), 236-245.
77. Alnouti, Y.; Klaassen, C. D. Regulation of sulfotransferase enzymes by prototypical microsomal enzyme inducers in mice. J.Pharmacol. Exp. Ther., 2008, 324(2), 612-621. (Pubitemid 351185863)
78. Chen, X.; Zhang, J.; Baker, S. M.; Chen, G. Human constitutive androstane receptor mediated methotrexate induction of human dehydroepiandrosterone sulfotransferase (hSULT2A1). Toxicology, 2007, 231(2-3), 224-233. (Pubitemid 46283167)
79. Chen, X.; Maiti, S.; Zhang, J.; Chen, G. Nuclear receptor interactions in methotrexate induction of human dehydroepiandrosterone sulfotransferase (hSULT2A1). J. Biochem. Mol. Toxicol., 2006, 20(6), 309-317. (Pubitemid 46025671)
80. Qian, Y. M.; Sun, X. J.; Tong, M. H.; Li, X. P.; Richa, J.; Song, W. C. Targeted disruption of the mouse estrogen sulfotransferase gene reveals a role of estrogen metabolism in intracrine and paracrine estrogen regulation. Endocrinology, 2001, 142(12), 5342-5350. (Pubitemid 33131967)
81. Tong, M. H.; Jiang, H.; Liu, P.; Lawson, J. A.; Brass, L. F.; Song, W. C. Spontaneous fetal loss caused by placental thrombosis in estrogen sulfotransferase-deficient mice. Nat. Med., 2005, 11(2), 153-159. (Pubitemid 40321350)
82. Suzuki, T.; Miki, Y.; Nakata, T.; Shiotsu, Y.; Akinaga, S.; Inoue, K.; Ishida, T.; Kimura, M.; Moriya, T.; Sasano, H. Steroid sulfatase and estrogen sulfotransferase in normal human tissue and breast carcinoma. J. Steroid Biochem. Mol. Biol., 2003, 86(3-5), 449-454. (Pubitemid 37412583)
83. Kwon, M. S.; Kim, S. J.; Lee, S. Y.; Jeong, J. H.; Lee, E. S.; Kang, H. S. Epigenetic silencing of the sulfotransferase 1A1 gene by hypermethylation in breast tissue. Oncol. Rep., 2006, 15(1), 27-32.
84. Schauss, S. J.; Henry, T.; Palmatier, R.; Halvorson, L.; Dannenbring, R.; Beckmann, J. D. Characterization of bovine tracheobronchial phenol sulphotransferase cDNA and detection of mRNA regulation by cortisol. Biochem. J., 1995, 311 (Pt 1), 209-217.
85. Beckmann, J. D.; Illig, M.; Bartzatt, R. Regulation of phenol sulfotransferase expression in cultured bovine bronchial epithelial cells by hydrocortisone. J.Cell Physiol., 1994, 160(3), 603-610. (Pubitemid 24288919)
86. Runge-Morris, M.; Rose, K.; Kocarek, T. A. Regulation of rat hepatic sulfotransferase gene expression by glucocorticoid hormones. Drug Metab Dispos, 1996, 24(10), 1095-1101. (Pubitemid 26346222)
87. Duanmu, Z.; Kocarek, T. A.; Runge-Morris, M. Transcriptional regulation of rat hepatic aryl sulfotransferase (SULT1A1) gene expression by glucocorticoids. Drug Metab. Dispos., 2001, 29(8), 1130-1135. (Pubitemid 32660532)
88. Fang, H. L.; Shenoy, S.; Duanmu, Z.; Kocarek, T. A.; Runge- Morris, M. Transactivation of glucocorticoid-inducible rat aryl sulfotransferase (SULT1A1) gene transcription. Drug Metab. Dispos., 2003, 31(11), 1378-1381. (Pubitemid 37310327)
89. Duanmu, Z.; Locke, D.; Smigelski, J.; Wu, W.; Dahn, M. S.; Falany, C. N.; Kocarek, T. A.; Runge-Morris, M. Effects of dexamethasone on aryl (SULT1A1)- and hydroxysteroid (SULT2A1)-sulfotransferase gene expression in primary cultured human hepatocytes. Drug Metab. Dispos., 2002, 30(9), 997-1004.
90. Song, C. S.; Jung, M. H.; Kim, S. C.; Hassan, T.; Roy, A. K.; Chatterjee, B. Tissue-specific and androgen-repressible regulation of the rat dehydroepiandrosterone sulfotransferase gene promoter. J. Biol. Chem., 1998, 273(34), 21856-21866. (Pubitemid 28405363)
91. Fang, H. L.; Abdolalipour, M.; Duanmu, Z.; Smigelski, J. R.; Weckle, A.; Kocarek, T. A.; Runge-Morris, M. Regulation of glucocorticoid-inducible hydroxysteroid sulfotransferase (SULT2A-40/41) gene transcription in primary cultured rat hepatocytes: Role of CCAAT/enhancer-binding protein liverenriched transcription factors. Drug Metab. Dispos., 2005, 33(1), 147-156. (Pubitemid 40023526)
92. Bian, H. S.; Ngo, S. Y.; Tan, W.; Wong, C. H.; Boelsterli, U. A.; Tan, T. M. Induction of human sulfotransferase 1A3 (SULT1A3) by glucocorticoids. Life Sci., 2007, 81(25-26), 1659-1667. (Pubitemid 350151445)
93. Zhang, H.; Varlamova, O.; Vargas, F. M.; Falany, C. N.; Leyh, T. S. Sulfuryl transfer: The catalytic mechanism of human estrogen sulfotransferase. J. Biol. Chem., 1998, 273(18), 10888-10892. (Pubitemid 28204925)
94. Gong, H.; Jarzynka, M. J.; Cole, T. J.; Lee, J. H.; Wada, T.; Zhang, B.; Gao, J.; Song, W. C.; DeFranco, D. B.; Cheng, S. Y.; Xie, W. Glucocorticoids antagonize estrogens by glucocorticoid receptormediated activation of estrogen sulfotransferase. Cancer Res., 2008, 68(18), 7386-7393.
95. Wong, S.; Tan, K.; Carey, K. T.; Fukushima, A.; Tiganis, T.; Cole, T. J. Glucocorticoids stimulate hepatic and renal catecholamine inactivation by direct rapid induction of the dopamine sulfotransferase Sult1d1. Endocrinology, 151(1), 185-194.
96. Dunn, R. T., 2nd; Gleason, B. A.; Hartley, D. P.; Klaassen, C. D. Postnatal ontogeny and hormonal regulation of sulfotransferase SULT1B1 in male and female rats. J. Pharmacol. Exp. Ther., 1999, 290(1), 319-324. (Pubitemid 29302338)
97. Luu-The, V.; Bernier, F.; Dufort, I. Steroid sulfotransferases. J. Endocrinol., 1996, 150 Suppl, S87-97.
98. Klaassen, C. D.; Liu, L.; Dunn, R. T., 2nd. Regulation of sulfotransferase mRNA expression in male and female rats of various ages. Chem. Biol. Interact., 1998, 109(1-3), 299-313. (Pubitemid 28161122)
99. Rubin, G. L.; Harrold, A. J.; Mills, J. A.; Falany, C. N.; Coughtrie, M. W. Regulation of sulphotransferase expression in the endometrium during the menstrual cycle, by oral contraceptives and during early pregnancy. Mol. Hum. Reprod., 1999, 5(11), 995-1002. (Pubitemid 29518902)
100. Tanaka, K.; Kubushiro, K.; Iwamori, Y.; Okairi, Y.; Kiguchi, K.; Ishiwata, I.; Tsukazaki, K.; Nozawa, S.; Iwamori, M. Estrogen sulfotransferase and sulfatase: Roles in the regulation of estrogen activity in human uterine endometrial carcinomas. Cancer Sci., 2003, 94(10), 871-876. (Pubitemid 37406969)
101. Falany, J. L.; Falany, C. N. Regulation of SULT1E1 expression in Ishikawa adenocarcinoma cells by tibolone. Steroids, 2006, 71(10), 880-885. (Pubitemid 44376404)
102. Deng, W. H.; Wu, Y. Y.; Luo, L. H.; Wang, S.; Tang, W. Q.; Zhang, Y. F. [Expression of estrogen sulfotransferase in breast tissues and the regulation of ESTmRNA by estrogen]. Zhonghua Yi Xue Za Zhi, 2003, 83(21), 1891-1894.
103. Campisi, I.; Granata, O. M.; Cocciadiferro, L.; Calabro, M.; Polito, L. M.; Carruba, G. 16alpha-hydroxyestrone inhibits estrogen sulfotransferase activity in human liver cancer cells. Ann. N. Y. Acad. Sci., 2009, 1155, 237-241.
104. Chen, Y.; Huang, C.; Zhou, T.; Chen, G. Genistein induction of human sulfotransferases in HepG2 and Caco-2 cells. Basic Clin. Pharmacol. Toxicol., 2008, 103(6), 553-559.
105. Mesia-Vela, S.; Kauffman, F. C. Inhibition of rat liver sulfotransferases SULT1A1 and SULT2A1 and glucuronosyltransferase by dietary flavonoids. Xenobiotica, 2003, 33(12), 1211-1220. (Pubitemid 38122243)
106. Stakhiv, T. M.; Mesia-Vela, S.; Kauffman, F. C. Phase II antioxidant enzyme activities in brain of male and female ACI rats treated chronically with estradiol. Brain Res., 2006, 1104(1), 80-91. (Pubitemid 44164435)
107. Demyan, W. F.; Song, C. S.; Kim, D. S.; Her, S.; Gallwitz, W.; Rao, T. R.; Slomczynska, M.; Chatterjee, B.; Roy, A. K. Estrogen sulfotransferase of the rat liver: Complementary DNA cloning and age- and sex-specific regulation of messenger RNA. Mol. Endocrinol., 1992, 6(4), 589-597.
108. Kumar, A.; Magoffin, D.; Munir, I.; Azziz, R. Effect of insulin and testosterone on androgen production and transcription of SULT2A1 in the NCI-H295R adrenocortical cell line. Fertil. Steril., 2009, 92(2), 793-797.
109. Khor, V. K.; Tong, M. H.; Qian, Y.; Song, W. C. Gender-specific expression and mechanism of regulation of estrogen sulfotransferase in adipose tissues of the mouse. Endocrinology, 2008, 149(11), 5440-5448.
110. Satoh, T.; Matsui, M.; Tamura, H. Sulfotransferases in a human colon carcinoma cell line, Caco-2. Biol. Pharm. Bull., 2000, 23(7), 810-814. (Pubitemid 30484376)
111. Echchgadda, I.; Song, C. S.; Roy, A. K.; Chatterjee, B. Dehydroepiandrosterone sulfotransferase is a target for transcriptional induction by the vitamin D receptor. Mol. Pharmacol., 2004, 65(3), 720-729. (Pubitemid 38264040)
112. Song, C. S.; Echchgadda, I.; Seo, Y. K.; Oh, T.; Kim, S.; Kim, S. A.; Cho, S.; Shi, L.; Chatterjee, B. An essential role of the CAAT/enhancer binding protein-alpha in the vitamin D-induced expression of the human steroid/bile acid-sulfotransferase (SULT2A1). Mol. Endocrinol., 2006, 20(4), 795-808.
113. Listowsky, I.; Abramovitz, M.; Homma, H.; Niitsu, Y. Intracellular binding and transport of hormones and xenobiotics by glutathione- S-transferases. Drug Metab. Rev., 1988, 19(3-4), 305-318. (Pubitemid 19043739)
114. Ishigaki, S.; Abramovitz, M.; Listowsky, I. Glutathione-Stransferases are major cytosolic thyroid hormone binding proteins. Arch. Biochem. Biophys., 1989, 273(2), 265-272. (Pubitemid 19221980)
115. Ladner, J. E.; Parsons, J. F.; Rife, C. L.; Gilliland, G. L.; Armstrong, R. N. Parallel evolutionary pathways for glutathione transferases: Structure and mechanism of the mitochondrial class kappa enzyme rGSTK1-1. Biochemistry, 2004, 43(2), 352-361. (Pubitemid 38082557)
116. Sheehan, D.; Meade, G.; Foley, V. M.; Dowd, C. A. Structure, function and evolution of glutathione transferases: Implications for classification of non-mammalian members of an ancient enzyme superfamily. Biochem. J., 2001, 360(Pt 1), 1-16. (Pubitemid 33081943)
117. Jakobsson, P. J.; Morgenstern, R.; Mancini, J.; Ford-Hutchinson, A.; Persson, B. Common structural features of MAPEG-a widespread superfamily of membrane associated proteins with highly divergent functions in eicosanoid and glutathione metabolism. Protein Sci., 1999, 8(3), 689-692. (Pubitemid 29117984)
118. Hayes, J. D.; Pulford, D. J. The glutathione S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit. Rev. Biochem. Mol. Biol., 1995, 30(6), 445-600.
119. Armstrong, R. N. Structure, catalytic mechanism, and evolution of the glutathione transferases. Chem. Res. Toxicol., 1997, 10(1), 2-18. (Pubitemid 27044902)
120. Ameen, M.; Musthapa, M. S.; Abidi, P.; Ahmad, I.; Rahman, Q. Garlic attenuates chrysotile-mediated pulmonary toxicity in rats by altering the phase I and phase II drug metabolizing enzyme system. J. Biochem. Mol. Toxicol., 2003, 17(6), 366-371. (Pubitemid 38072285)
121. Krajka-Kuzniak, V.; Szaefer, H.; Baer-Dubowska, W. Modulation of 3-methylcholanthrene-induced rat hepatic and renal cytochrome P450 and phase II enzymes by plant phenols: Protocatechuic and tannic acids. Toxicol. Lett., 2004, 152(2), 117-126. (Pubitemid 39061763)
122. Rae, J. M.; Johnson, M. D.; Lippman, M. E.; Flockhart, D. A. Rifampin is a selective, pleiotropic inducer of drug metabolism genes in human hepatocytes: Studies with cDNA and oligonucleotide expression arrays. J. Pharmacol. Exp. Ther., 2001, 299(3), 849-857. (Pubitemid 33104951)
123. Patten, E. J.; DeLong, M. J. Effects of sulindac, sulindac metabolites, and aspirin on the activity of detoxification enzymes in HT-29 human colon adenocarcinoma cells. Cancer Lett., 1999, 147(1-2), 95-100.
124. DePierre, J. W.; Seidegard, J.; Morgenstern, R.; Balk, L.; Meijer, J.; Astrom, A.; Norelius, I.; Ernster, L. Induction of cytosolic glutathione transferase and microsomal epoxide hydrolase activities in extrahepatic organs of the rat by phenobarbital, 3-methylcholanthrene and trans-stilbene oxide. Xenobiotica, 1984, 14(4), 295-301. (Pubitemid 14108121)
125. Tang, N. J.; Liu, J.; Coenraads, P. J.; Dong, L.; Zhao, L. J.; Ma, S. W.; Chen, X.; Zhang, C. M.; Ma, X. M.; Wei, W. G.; Zhang, P.; Bai, Z. P. Expression of AhR, CYP1A1, GSTA1, c-fos and TGFalpha in skin lesions from dioxin-exposed humans with chloracne. Toxicol. Lett., 2008, 177(3), 182-187.
126. Knight, T. R.; Choudhuri, S.; Klaassen, C. D. Induction of hepatic glutathione S-transferases in male mice by prototypes of various classes of microsomal enzyme inducers. Toxicol. Sci., 2008, 106(2), 329-338.
127. Datta, S. K.; Kumar, V.; Ahmed, R. S.; Tripathi, A. K.; Kalra, O. P.; Banerjee, B. D. Effect of GSTM1 and GSTT1 double deletions in the development of oxidative stress in diabetic nephropathy patients. Indian J. Biochem. Biophys., 47(2), 100-103.
128. Safarinejad, M. R.; Shafiei, N.; Safarinejad, S. The association of glutathione-S-transferase gene polymorphisms (GSTM1, GSTT1, GSTP1) with idiopathic male infertility. J. Hum. Genet., 2010, 55, 565-570.
129. Sherratt, A. J.; Banet, D. E.; Prough, R. A. Glucocorticoid regulation of polycyclic aromatic hydrocarbon induction of cytochrome P450IA1, glutathione S-transferases, and NAD(P) H:quinone oxidoreductase in cultured fetal rat hepatocytes. Mol. Pharmacol., 1990, 37(2), 198-205. (Pubitemid 20082983)
130. Gebhardt, R.; Fitzke, H.; Fausel, M.; Eisenmann-Tappe, I.; Mecke, D. Influence of hormones and drugs on glutathione-S-transferase levels in primary culture of adult rat hepatocytes. Cell Biol. Toxicol., 1990, 6(4), 365-378.
131. de Waziers, I.; Bouguet, J.; Beaune, P. H.; Gonzalez, F. J.; Ketterer, B.; Barouki, R. Effects of ethanol, dexamethasone and RU 486 on expression of cytochromes P450 2B, 2E, 3A and glutathione transferase pi in a rat hepatoma cell line (Fao). Pharmacogenetics, 1992, 2(1), 12-18.
132. Schwartz, D. A.; Norris, J. S. Glucocorticoid, androgen, and retinoic acid regulation of glutathione S-transferase gene expression in hamster smooth muscle tumor cells. Biochem. Biophys. Res. Commun., 1992, 184(2), 1108-1113.
133. Fan, W.; Trifiletti, R.; Cooper, T.; Norris, J. S. Cloning of a muclass glutathione S-transferase gene and identification of the glucocorticoid
134. Sakai, M.; Muramatsu, M.; Nishi, S. Suppression of glutathione transferase P expression by glucocorticoid. Biochem. Biophys. Res. Commun., 1992, 187(2), 976-983.
135. Aoki, Y.; Matsumoto, M.; Suzuki, K. T. Expression of glutathione S-transferase P-form in primary cultured rat liver parenchymal cells by coplanar polychlorinated biphenyl congeners is suppressed by protein kinase inhibitors and dexamethasone. FEBS Lett., 1993, 333(1-2), 114-118. (Pubitemid 23306950)
136. Voss, S. H.; Park, Y.; Kwon, S. O.; Whalen, R.; Boyer, T. D. Role of interleukin 6 and corticosteroids in the regulation of expression of glutathione S-transferases in primary cultures of rat hepatocytes. Biochem. J., 1996, 317 (Pt 2), 627-632. (Pubitemid 26254005)
137. Prough, R. A.; Linder, M. W.; Pinaire, J. A.; Xiao, G. H.; Falkner, K. C. Hormonal regulation of hepatic enzymes involved in foreign compound metabolism. Faseb J., 1996, 10(12), 1369-1377. (Pubitemid 26347871)
138. Falkner, K. C.; Rushmore, T. H.; Linder, M. W.; Prough, R. A. Negative regulation of the rat glutathione S-transferase A2 gene by glucocorticoids involves a canonical glucocorticoid consensus sequence. Mol. Pharmacol., 1998, 53(6), 1016-1026. (Pubitemid 28280443)
139. Falkner, K. C.; Pinaire, J. A.; Xiao, G. H.; Geoghegan, T. E.; Prough, R. A. Regulation of the rat glutathione S-transferase A2 gene by glucocorticoids: Involvement of both the glucocorticoid and pregnane X receptors. Mol. Pharmacol., 2001, 60(3), 611-619. (Pubitemid 32781569)
140. Ki, S. H.; Cho, I. J.; Choi, D. W.; Kim, S. G. Glucocorticoid receptor (GR)-associated SMRT binding to C/EBPbeta TAD and Nrf2 Neh4/5: Role of SMRT recruited to GR in GSTA2 gene repression. Mol. Cell Biol., 2005, 25(10), 4150-4165.
141. Falkner, K. C.; Prough, R. A. Regulation of the rat glutathione Stransferase A2 gene by glucocorticoids: Crosstalk through C/EBPs. Drug Metab. Rev., 2007, 39(2-3), 401-418. (Pubitemid 47355729)
142. Hosono, N.; Kishi, S.; Iho, S.; Urasaki, Y.; Yoshida, A.; Kurooka, H.; Yokota, Y.; Ueda, T. Glutathione S-transferase M1 inhibits dexamethasone-induced apoptosis in association with the suppression of Bim through dual mechanisms in a lymphoblastic leukemia cell line. Cancer Sci., 101(3), 767-773.
143. Nam, S. Y.; Cho, C. K.; Kim, S. G. Correlation of increased mortality with the suppression of radiation-inducible microsomal epoxide hydrolase and glutathione S-transferase gene expression by dexamethasone: Effects on vitamin C and E-induced radioprotection. Biochem. Pharmacol., 1998, 56(10), 1295-1304. (Pubitemid 28512677)
144. Sardar, S.; Chatterjee, M.; Ghosh, S.; Roy, K. Role of vitamin D3 on the activity patterns of hepatic drug metabolizing enzymes in transplantable murine lymphoma. Cancer Invest., 1996, 14(4), 328-334. (Pubitemid 26249170)
145. Banakar, M. C.; Paramasivan, S. K.; Chattopadhyay, M. B.; Datta, S.; Chakraborty, P.; Chatterjee, M.; Kannan, K.; Thygarajan, E. 1alpha, 25-dihydroxyvitamin D3 prevents DNA damage and restores antioxidant enzymes in rat hepatocarcinogenesis induced by diethylnitrosamine and promoted by phenobarbital. World J. Gastroenterol., 2004, 10(9), 1268-1275. (Pubitemid 39162429)
146. Hambali, Z.; Ngah, W. Z.; Wahid, S. A.; Kadir, K. A. Effect of ovariectomy and sex hormone replacement on glutathione and glutathione-related enzymes in rat hepatocarcinogenesis. Pathology, 1995, 27(1), 30-35.
147. Pajovic, S. B.; Saicic, Z. S.; Spasic, M. B.; Petrovic, V. M.; Martinovic, J. V. Effects of progesterone and estradiol benzoate on glutathione dependent antioxidant enzyme activities in the brain of female rats. Gen. Physiol. Biophys., 1999, 18(1), 35-44. (Pubitemid 29238792)
148. Pushpalatha, T.; Reddy, P. R.; Reddy, P. S. Alterations in hepatic metabolism of adult male rats following exposure to hydroxyprogesterone during embryonic development. Asian J. Androl., 2006, 8(4), 463-467. (Pubitemid 44304492)
149. Ni, H.; Yu, X. J.; Liu, H. J.; Lei, W.; Rengaraj, D.; Li, X. J.; Yang, Z. M. Progesterone regulation of glutathione S-transferase Mu2 expression in mouse uterine luminal epithelium during preimplantation period. Fertil. Steril., 2009, 91(5 Suppl), 2123-2130.
150. Hatayama, I.; Satoh, K.; Sato, K. Developmental and hormonal regulation of the major form of hepatic glutathione S-transferase in male mice. Biochem. Biophys. Res. Commun., 1986, 140(2), 581-588. (Pubitemid 17190101)
151. Chang, C. S.; Saltzman, A. G.; Sorensen, N. S.; Hiipakka, R. A.; Liao, S. S. Identification of glutathione S-transferase Yb1 mRNA as the androgen-repressed mRNA by cDNA cloning and sequence analysis. J. Biol. Chem., 1987, 262(25), 11901-11903.
152. Staffas, L.; Ellis, E. M.; Hayes, J. D.; Lundgren, B.; Depierre, J. W.; Mankowitz, L. Growth hormone- and testosterone-dependent regulation of glutathione transferase subunit A5 in rat liver. Biochem. J., 1998, 332 (Pt 3), 763-768. (Pubitemid 28306703)
153. Coecke, S.; Vanhaecke, T.; Foriers, A.; Phillips, I. R.; Vercruysse, A.; Shephard, E. A.; Rogiers, V. Hormonal regulation of glutathione S-transferase expression in co-cultured adult rat hepatocytes. J. Endocrinol., 2000, 166(2), 363-371. (Pubitemid 30650573)
154. Catania, V. A.; Luquita, M. G.; Sanchez Pozzi, E. J.; Mottino, A. D. Quantitative and qualitative gender-related differences in jejunal glutathione S-transferase in the rat effect of testosterone administration. Life Sci., 2000, 68(4), 467-474. (Pubitemid 32011898)
155. Benbrahim-Tallaa, L.; Tabone, E.; Tosser-Klopp, G.; Hatey, F.; Benahmed, M. Glutathione S-transferase alpha expressed in porcine Sertoli cells is under the control of follicle-stimulating hormone and testosterone. Biol. Reprod., 2002, 66(6), 1734-1742. (Pubitemid 34547270)
156. Townsend, A. J.; Morrow, C. S.; Sinha, B. K.; Cowan, K. H. Selenium-dependent glutathione peroxidase expression is inversely related to estrogen receptor content of human breast cancer cells. Cancer Commun., 1991, 3(8), 265-270.
157. Moscow, J. A.; Townsend, A. J.; Goldsmith, M. E.; Whang-Peng, J.; Vickers, P. J.; Poisson, R.; Legault-Poisson, S.; Myers, C. E.; Cowan, K. H. Isolation of the human anionic glutathione Stransferase cDNA and the relation of its gene expression to estrogen-receptor content in primary breast cancer. Proc. Natl. Acad. Sci. U S A, 1988, 85(17), 6518-6522.
158. Morrow, C. S.; Chiu, J.; Cowan, K. H. Posttranscriptional control of glutathione S-transferase pi gene expression in human breast cancer cells. J. Biol. Chem., 1992, 267(15), 10544-10550.
159. Jhaveri, M. S.; Stephens, T. E.; Morrow, C. S. Role of posttranscriptional processes in the regulation of glutathione Stransferase P1 gene expression in human breast cancer cells. Biochem. Biophys. Res. Commun., 1997, 237(3), 729-734. (Pubitemid 27434756)
160. Jhaveri, M. S.; Morrow, C. S. Contribution of proximal promoter elements to the regulation of basal and differential glutathione Stransferase P1 gene expression in human breast cancer cells. Biochim. Biophys. Acta, 1998, 1396(2), 179-190. (Pubitemid 28150180)
161. Jhaveri, M. S.; Morrow, C. S. Methylation-mediated regulation of the glutathione S-transferase P1 gene in human breast cancer cells. Gene, 1998, 210(1), 1-7. (Pubitemid 28156380)
162. Singh, D.; Pandey, R. S. Glutathione-S-transferase in rat ovary: Its changes during estrous cycle and increase in its activity by estradiol-17 beta. Indian J. Exp. Biol., 1996, 34(11), 1158-1160.
163. Sanchez, R. I.; Mesia-Vela, S.; Kauffman, F. C. Induction of NAD(P)H quinone oxidoreductase and glutathione S-transferase activities in livers of female August-Copenhagen Irish rats treated chronically with estradiol: Comparison with the Sprague-Dawley rat. J. Steroid Biochem. Mol. Biol., 2003, 87(2-3), 199-206. (Pubitemid 37532527)
164. Montano, M. M.; Deng, H.; Liu, M.; Sun, X.; Singal, R. Transcriptional regulation by the estrogen receptor of antioxidative stress enzymes and its functional implications. Oncogene, 2004, 23(14), 2442-2453. (Pubitemid 38520742)
165. Han, W.; Pentecost, B. T.; Pietropaolo, R. L.; Fasco, M. J.; Spivack, S. D. Estrogen receptor alpha increases basal and cigarette smoke extract-induced expression of CYP1A1 and CYP1B1, but not GSTP1, in normal human bronchial epithelial cells. Mol. Carcinog., 2005, 44(3), 202-211. (Pubitemid 41552753)
166. Blum, M.; Grant, D. M.; McBride, W.; Heim, M.; Meyer, U. A. Human arylamine N-acetyltransferase genes: Isolation, chromosomal localization, and functional expression. DNA Cell Biol., 1990, 9(3), 193-203.
167. Sim, E.; Walters, K.; Boukouvala, S. Arylamine N-acetyltransferases: From structure to function. Drug Metab. Rev., 2008, 40(3), 479-510. (Pubitemid 352019961)
168. Vatsis, K. P.; Weber, W. W. In: Handbook of experimental pharmacology; Kauffman FC, Ed.; Springer Verlag, New York, 1994; Vol. 112, pp. 109-130.
169. Dupret, J. M.; Goodfellow, G. H.; Janezic, S. A.; Grant, D. M. Structure-function studies of human arylamine N-acetyltransferases NAT1 and NAT2. Functional analysis of recombinant NAT1/NAT2 chimeras expressed in Escherichia coli. J. Biol. Chem., 1994, 269(43), 26830-26835.
170. Arlt, V. M.; Glatt, H.; Muckel, E.; Pabel, U.; Sorg, B. L.; Schmeiser, H. H.; Phillips, D. H. Metabolic activation of the environmental contaminant 3-nitrobenzanthrone by human acetyltransferases and sulfotransferase. Carcinogenesis, 2002, 23(11), 1937-1945. (Pubitemid 35355944)
171. Ragunathan, N.; Dairou, J.; Pluvinage, B.; Martins, M.; Petit, E.; Janel, N.; Dupret, J. M.; Rodrigues-Lima, F. Identification of the xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 as a new target of cisplatin in breast cancer cells: Molecular and cellular mechanisms of inhibition. Mol. Pharmacol., 2008, 73(6), 1761-1768. (Pubitemid 351724363)
172. Rodrigues-Lima, F.; Dairou, J.; Busi, F.; Dupret, J. M. Human arylamine N-acetyltransferase 1: A drug-metabolizing enzyme and a drug target? Curr. Drug Targets, 11(6), 759-766.
173. Hein, D. W. Molecular genetics and function of NAT1 and NAT2: Role in aromatic amine metabolism and carcinogenesis. Mutat. Res., 2002, 506-507, 65-77. (Pubitemid 35286541)
174. Mitchell, R. S.; Bell, J. C. Clinical implications of isoniazid blood levels in pulmonary tuberculosis. N. Engl. J. Med., 1957, 257(22), 1066-1070.
175. Jenne, J. W.; Macdonald, F. M.; Mendoza, E. A study of the renal clearances, metabolic inactivation rates, and serum fall-off interaction of isoniazid and paraminosalicylic acid in man. Am. Rev. Respir. Dis., 1961, 84, 371-378.
176. Evans, D. A.; White, T. A. Human Acetylation Polymorphism. J. Lab Clin. Med., 1964, 63, 394-403.
177. Hein, D. W.; McQueen, C. A.; Grant, D. M.; Goodfellow, G. H.; Kadlubar, F. F.; Weber, W. W. Pharmacogenetics of the arylamine N-acetyltransferases: A symposium in honor of Wendell W. Weber. Drug Metab. Dispos., 2000, 28(12), 1425-1432.
178. Jennne, J. W. Partial purification and properties of the isoniazid transacetylase in human liver. Its relationship to the acetylation of p-aminosalicylic acid. J. Clin. Invest., 1965, 44(12), 1992-2002.
179. Weber, W. W. The acetylator genes and drug response. Oxford University Press, New York, 1987.
180. Vatsis, K. P.; Weber, W. W. Structural heterogeneity of Caucasian N-acetyltransferase at the NAT1 gene locus. Arch. Biochem. Biophys., 1993, 301(1), 71-76. (Pubitemid 23227178)
181. Wakefield, L.; Robinson, J.; Long, H.; Ibbitt, J. C.; Cooke, S.; Hurst, H. C.; Sim, E. Arylamine N-acetyltransferase 1 expression in breast cancer cell lines: A potential marker in estrogen receptorpositive tumors. Genes Chromosomes Cancer, 2008, 47(2), 118-126.
182. Soreide, J. A.; Lea, O. A.; Varhaug, J. E.; Skarstein, A.; Kvinnsland, S. Androgen receptors in operable breast cancer: Relation to other steroid hormone receptors, correlations to prognostic factors and predictive value for effect of adjuvant tamoxifen treatment. Eur. J. Surg. Oncol., 1992, 18(2), 112-118.
183. Hein, D. W.; Leff, M. A.; Ishibe, N.; Sinha, R.; Frazier, H. A.; Doll, M. A.; Xiao, G. H.; Weinrich, M. C.; Caporaso, N. E. Association of prostate cancer with rapid N-acetyltransferase 1 (NAT110) in combination with slow N-acetyltransferase 2 acetylator genotypes in a pilot case-control study. Environ. Mol. Mutagen, 2002, 40(3), 161-167.
184. Butcher, N. J.; Tiang, J.; Minchin, R. F. Regulation of arylamine N-acetyltransferases. Curr. Drug Metab., 2008, 9(6), 498-504. (Pubitemid 352025180)
185. Rodrigues-Lima, F.; Dupret, J. M. Regulation of the activity of the human drug metabolizing enzyme arylamine N-acetyltransferase 1: Role of genetic and non genetic factors. Curr. Pharm Des., 2004, 10(20), 2519-2524. (Pubitemid 38997431)
186. Butcher, N. J.; Arulpragasam, A.; Goh, H. L.; Davey, T.; Minchin, R. F. Genomic organization of human arylamine Nacetyltransferase Type I reveals alternative promoters that generate different 5'-UTR splice variants with altered translational activities. Biochem. J., 2005, 387(Pt 1), 119-127. (Pubitemid 40524081)
187. Ebisawa, T.; Deguchi, T. Structure and restriction fragment length polymorphism of genes for human liver arylamine Nacetyltransferases. Biochem. Biophys. Res. Commun., 1991, 177(3), 1252-1257.
188. Boukouvala, S.; Price, N.; Plant, K. E.; Sim, E. Structure and transcriptional regulation of the Nat2 gene encoding for the drugmetabolizing enzyme arylamine N-acetyltransferase type 2 in mice. Biochem J, 2003, 375(Pt 3), 593-602. (Pubitemid 37433507)
189. Husain, A.; Barker, D. F.; States, J. C.; Doll, M. A.; Hein, D. W. Identification of the major promoter and non-coding exons of the human arylamine N-acetyltransferase 1 gene (NAT1). Pharmacogenetics, 2004, 14(7), 397-406. (Pubitemid 38971230)
190. Wang, C. Y.; Debiec-Rychter, M.; Schut, H. A.; Morse, P.; Jones, R. F.; Archer, C.; King, C. M.; Haas, G. P. N-Acetyltransferase expression and DNA binding of N-hydroxyheterocyclic amines in human prostate epithelium. Carcinogenesis, 1999, 20(8), 1591-1595. (Pubitemid 29385450)
191. Al-Buheissi, S. Z.; Patel, H. R.; Meinl, W.; Hewer, A.; Bryan, R. L.; Glatt, H.; Miller, R. A.; Phillips, D. H. N-Acetyltransferase and sulfotransferase activity in human prostate: Potential for carcinogen activation. Pharmacogenet. Genomics, 2006, 16(6), 391-399. (Pubitemid 43804797)
192. Smolen, T. N.; Brewer, J. A.; Weber, W. W. Testosterone modulation of N-acetylation in mouse kidney. J. Pharmacol. Exp. Ther., 1993, 264(2), 854-858. (Pubitemid 24283550)
193. DePrimo, S. E.; Diehn, M.; Nelson, J. B.; Reiter, R. E.; Matese, J.; Fero, M.; Tibshirani, R.; Brown, P. O.; Brooks, J. D. Transcriptional programs activated by exposure of human prostate cancer cells to androgen. Genome Biol., 2002, 3(7), RESEARCH0032.
194. Butcher, N. J.; Tetlow, N. L.; Cheung, C.; Broadhurst, G. M.; Minchin, R. F. Induction of human arylamine N-acetyltransferase type I by androgens in human prostate cancer cells. Cancer Res., 2007, 67(1), 85-92. (Pubitemid 46142762)
195. Ing, N. H. Steroid hormones regulate gene expression posttranscriptionally by altering the stabilities of messenger RNAs. Biol. Reprod., 2005, 72(6), 1290-1296. (Pubitemid 40696071)
196. Butcher, N. J.; Minchin, R. F. Arylamine N-acetyltransferase 1 gene regulation by androgens requires a conserved heat shock element for heat shock factor-1. Carcinogenesis, 31(5), 820-826.
197. Lotta, T.; Vidgren, J.; Tilgmann, C.; Ulmanen, I.; Melen, K.; Julkunen, I.; Taskinen, J. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: A revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry, 1995, 34(13), 4202-4210.
198. Jeffery, D. R.; Roth, J. A. Characterization of membrane-bound and soluble catechol-O-methyltransferase from human frontal cortex. J. Neurochem., 1984, 42(3), 826-832. (Pubitemid 14198969)
199. Rivett, A. J.; Francis, A.; Roth, J. A. Localization of membranebound catechol-O-methyltransferase. J. Neurochem., 1983, 40(5), 1494-1496.
200. Pavel, S. Dynamics of melanogenesis intermediates. J. Invest. Dermatol., 1993, 100(2 Suppl), 162S-165S. (Pubitemid 23051692)
201. Borchardt, R. T. Enzymatic basis of detoxification; Vol. 2. Academic Press: New York, 1980.
202. Blaschke, E.; Hertting, G. Enzymic methylation of L-ascorbic acid by catechol O-methyltransferase. Biochem. Pharmacol., 1971, 20(7), 1363-1370.
203. Borchardt, R. T. Methods in enzymology; Vol. 77. Academic Press: New York, 1981.
204. Creveling, C. R.; Thakker, D.R. In: Handbook of experimental pharmacology; Kauffman FC, Ed.; Springer Verlag: New York, 1994; Vol. 112, pp.
205. Roy, D.; Weisz, J.; Liehr, J. G. The O-methylation of 4- hydroxyestradiol is inhibited by 2-hydroxyestradiol: Implications for estrogen-induced carcinogenesis. Carcinogenesis, 1990, 11(3), 459-462. (Pubitemid 20079400)
206. Assicot, M.; Contesso, G.; Bohuon, C. Catechol-O-methyltransferase in human breast cancers. Eur. J. Cancer, 1977, 13(9), 961-966.
207. Hoffman, A. R.; Paul, S. M.; Axelrod, J. Catecholestrogen synthesis and metabolism by human breast tumors in vitro. Cancer Res, 1979, 39(11), 4584-4587. (Pubitemid 10198635)
208. Longcope, C. In: Catechol estrogens; Merriam GR and Lipsett MB, Ed.; Raven Press: New York, 1983; Vol., pp.
209. Tenhunen, J.; Salminen, M.; Lundstrom, K.; Kiviluoto, T.; Savolainen, R.; Ulmanen, I. Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters. Eur. J. Biochem., 1994, 223(3), 1049-1059. (Pubitemid 24263190)
210. Ulmanen, I.; Lundstrom, K. Cell-free synthesis of rat and human catechol O-methyltransferase. Insertion of the membrane-bound form into microsomal membranes in vitro. Eur. J. Biochem., 1991, 202(3), 1013-1020.
211. Tenhunen, J.; Ulmanen, I. Production of rat soluble and membranebound catechol O-methyltransferase forms from bifunctional mRNAs. Biochem. J., 1993, 296 (Pt 3), 595-600. (Pubitemid 24008173)
212. Tenhunen, J.; Salminen, M.; Jalanko, A.; Ukkonen, S.; Ulmanen, I. Structure of the rat catechol-O-methyltransferase gene: Separate promoters are used to produce mRNAs for soluble and membranebound forms of the enzyme. DNA Cell Biol., 1993, 12(3), 253-263. (Pubitemid 23121007)
213. Chen, J.; Lipska, B. K.; Halim, N.; Ma, Q. D.; Matsumoto, M.; Melhem, S.; Kolachana, B. S.; Hyde, T. M.; Herman, M. M.; Apud, J.; Egan, M. F.; Kleinman, J. E.; Weinberger, D. R. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brain. Am. J. Hum. Genet., 2004, 75(5), 807-821. (Pubitemid 39390488)
214. Lachman, H. M.; Papolos, D. F.; Saito, T.; Yu, Y. M.; Szumlanski, C. L.; Weinshilboum, R. M. Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics, 1996, 6(3), 243-250. (Pubitemid 26226317)
215. Parvez, S.; Parvez, S. H.; Youdim, M. B. Variation in activity of monoamine metabolizing enzymes in rat liver during pregnancy. Br. J. Pharmacol., 1975, 53(2), 241-246.
216. Parvez, H.; Parvez, S.; Raza-Bukhari, A. Decreased phenylethanolamine- N-methyltransferase and catechol-O-methyltransferase activity in rabbit adrenal glands during pregnancy. Br. J. Pharmacol., 1976, 57(3), 413-416.
217. Inoue, K.; Creveling, C. R. Induction of catechol-Omethyltransferase in the luminal epithelium of rat uterus by progesterone. J. Histochem. Cytochem., 1991, 39(6), 823-828.
218. Fahndrich, E.; Coper, H.; Christ, W.; Helmchen, H.; Muller- Oerlinghausen, B.; Pietzcker, A. Erythrocyte COMT-activity in patients with affective disorders. Acta Psychiatr. Scand., 1980, 61(5), 427-437. (Pubitemid 10076766)
219. Floderus, Y.; Ross, S. B.; Wetterberg, L. Erythrocyte catechol-Omethyltransferase activity in a Swedish population. Clin. Genet., 1981, 19(5), 389-392.
220. Boudikova, B.; Szumlanski, C.; Maidak, B.; Weinshilboum, R. Human liver catechol-O-methyltransferase pharmacogenetics. Clin. Pharmacol. Ther., 1990, 48(4), 381-389. (Pubitemid 20362271)
221. Xie, T.; Ho, S. L.; Ramsden, D. Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Mol. Pharmacol., 1999, 56(1), 31-38. (Pubitemid 29309809)
222. Stein, B.; Yang, M. X. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta. Mol. Cell Biol., 1995, 15(9), 4971-4979.
223. Galien, R.; Evans, H. F.; Garcia, T. Involvement of CCAAT/enhancer- binding protein and nuclear factor-kappa B binding sites in interleukin-6 promoter inhibition by estrogens. Mol.Endocrinol., 1996, 10(6), 713-722. (Pubitemid 26176279)
224. Jiang, H.; Xie, T.; Ramsden, D. B.; Ho, S. L. Human catechol- Omethyltransferase down-regulation by estradiol. Neuropharmacology, 2003, 45(7), 1011-1018.
225. Harrison, P. J.; Tunbridge, E. M. Catechol-O-methyltransferase (COMT): A gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders. Neuropsychopharmacology, 2008, 33(13), 3037-3045.
226. Remy, C. N. Metabolism of thiopyrimidines and thiopurines. SMethylation with S-adenosylmethionine transmethylase and catabolism in mammalian tissues. J. Biol. Chem, 1963, 238, 1078-1084.
227. Woodson, L. C.; Weinshilboum, R. M. Human kidney thiopurine methyltransferase. Purification and biochemical properties. Biochem. Pharmacol., 1983, 32(5), 819-826. (Pubitemid 13128727)
228. Deininger, M.; Szumlanski, C. L.; Otterness, D. M.; Van Loon, J.; Ferber, W.; Weinshilboum, R. M. Purine substrates for human thiopurine methyltransferase. Biochem. Pharmacol., 1994, 48(11), 2135-2138. (Pubitemid 24359621)
229. Paterson, A.R.P.; Tidd, D.M. In: Antineoplastic and immunosuppressive agents. Part 2.; Sartorelli AC and Johns DG, Ed.; Springer Verlag: New York, 1975; Vol., pp.
230. Borchardt, R. T.; Cheng, C. F. Purification and characterization of rat liver microsomal thiol methyltransferase. Biochim. Biophys. Acta, 1978, 522(2), 340-353. (Pubitemid 8274348)
231. Weisiger, R. A.; Jakoby, W. B. Thiol S-methyltransferase from rat liver. Arch Biochem. Biophys., 1979, 196(2), 631-637. (Pubitemid 10230171)
232. Weisiger, R. A.; Jakoby, W. B. Enzymatic Basis of Detoxication; Vol. 2. Academic Press: New York, 1980.
233. Ujiie, S.; Sasaki, T.; Mizugaki, M.; Ishikawa, M.; Hiratsuka, M. Functional characterization of 23 allelic variants of thiopurine Smethyltransferase gene (TPMT*2-*24). Pharmacogenet. Genomics, 2008, 18(10), 887-893.
234. Krynetski, E. Y.; Tai, H. L.; Yates, C. R.; Fessing, M. Y.; Loennechen, T.; Schuetz, J. D.; Relling, M. V.; Evans, W. E. Genetic polymorphism of thiopurine S-methyltransferase: Clinical importance and molecular mechanisms. Pharmacogenetics, 1996, 6(4), 279-290. (Pubitemid 26288618)
235. Weinshilboum, R. M.; Sladek, S. L. Mercaptopurine pharmacogenetics: Monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am. J. Hum. Genet., 1980, 32(5), 651-662. (Pubitemid 10061685)
236. Topic, E., Pharmacogenetic and tumour drugs-2005 http:// www.ifcc.org/ejifcc/vol16no2/160206200512.html (Accessed August 11, 2010).
237. Szumlanski, C.; Otterness, D.; Her, C.; Lee, D.; Brandriff, B.; Kelsell, D.; Spurr, N.; Lennard, L.; Wieben, E.; Weinshilboum, R. Thiopurine methyltransferase pharmacogenetics: Human gene cloning and characterization of a common polymorphism. DNA Cell Biol., 1996, 15(1), 17-30. (Pubitemid 26029354)
238. Tai, H. L.; Krynetski, E. Y.; Yates, C. R.; Loennechen, T.; Fessing, M. Y.; Krynetskaia, N. F.; Evans, W. E. Thiopurine Smethyltransferase deficiency: Two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians. Am. J. Hum. Genet., 1996, 58(4), 694-702. (Pubitemid 26086658)
239. Dong, X. W.; Zheng, Q.; Zhu, M. M.; Tong, J. L.; Ran, Z. H. Thiopurine S-methyltransferase polymorphisms and thiopurine toxicity in treatment of inflammatory bowel disease. World J. Gastroenterol., 16(25), 3187-3195.
240. Lennard, L.; Van Loon, J. A.; Lilleyman, J. S.; Weinshilboum, R. M. Thiopurine pharmacogenetics in leukemia: Correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations. Clin. Pharmacol. Ther., 1987, 41(1), 18-25. (Pubitemid 17008125)
241. Szumlanski, C. L.; Honchel, R.; Scott, M. C.; Weinshilboum, R. M. Human liver thiopurine methyltransferase pharmacogenetics: Biochemical properties, liver-erythrocyte correlation and presence of isozymes. Pharmacogenetics, 1992, 2(4), 148-159.
242. Weinshilboum, R. M.; Raymond, F. A.; Pazmino, P. A. Human erythrocyte thiopurine methyltransferase: Radiochemical microassay and biochemical properties. Clin. Chim. Acta, 1978, 85(3), 323-333. (Pubitemid 8333694)
243. Fessing, M. Y.; Krynetski, E. Y.; Zambetti, G. P.; Evans, W. E. Functional characterization of the human thiopurine Smethyltransferase (TPMT) gene promoter. Eur. J. Biochem., 1998, 256(3), 510-517. (Pubitemid 28440416)
244. Krynetski, E. Y.; Fessing, M. Y.; Yates, C. R.; Sun, D.; Schuetz, J. D.; Evans, W. E. Promoter and intronic sequences of the human thiopurine S-methyltransferase (TPMT) gene isolated from a human PAC1 genomic library. Pharm. Res., 1997, 14(12), 1672-1678. (Pubitemid 28062909)
245. Spire-Vayron de la Moureyre, C.; Debuysere, H.; Fazio, F.; Sergent, E.; Bernard, C.; Sabbagh, N.; Marez, D.; Lo Guidice, J. M.; D'Halluin J, C.; Broly, F. Characterization of a variable number tandem repeat region in the thiopurine S-methyltransferase gene promoter. Pharmacogenetics, 1999, 9(2), 189-198. (Pubitemid 29359001)
246. Calaf, G. M.; Roy, D. Human drug metabolism genes in parathionand estrogen-treated breast cells. Int. J. Mol. Med., 2007, 20(6), 875-881.
247. Knights, K. M.; Sykes, M. J.; Miners, J. O. Amino acid conjugation: Contribution to the metabolism and toxicity of xenobiotic carboxylic acids. Expert Opin. Drug Metab. Toxicol., 2007, 3(2), 159-168. (Pubitemid 47316038)
248. Levy, G. Pharmacokinetics of salicylate elimination in man. J. Pharm. Sci., 1965, 54(7), 959-967.
249. Mawal, Y.; Paradis, K.; Qureshi, I. A. Developmental profile of mitochondrial glycine N-acyltransferase in human liver. J. Pediatr., 1997, 130(6), 1003-1007. (Pubitemid 27495135)